<DOC>
	<DOCNO>NCT00174525</DOCNO>
	<brief_summary>This research study ass whether AAB-001 safe , well tolerated effective use patient Alzheimer 's Disease . AAB-001 new drug available outside study . AAB-001 antibody ( type protein usually produce white blood cell destroy substance body ) . In Alzheimer 's disease protein call amyloid gather brain thought cause symptom like memory loss confusion . It hop AAB-001 attach amyloid protein brain help body remove .</brief_summary>
	<brief_title>Safety Study Passive Immunization Patients With Mild Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Diagnosis probable AD Age 50 85 year , inclusive Rosen Modified Hachinski ischemic score less equal 4 Magnetic Resonance Imaging ( MRI ) scan consistent diagnosis AD Fluency English Stable dose medication Significant neurological disease AD Major psychiatric disorder Significant systemic illness History stroke seizure Weight great 120kg ( 264 lb . ) History autoimmune disease Smoking 20 cigarette per day Anticonvulsants , antiParkinson 's , anticoagulant , narcotic medication Prior treatment experimental immunotherapeutics vaccine AD Presence pacemaker foreign metal object eye , skin , body</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Alzheimer 's Caregivers</keyword>
	<keyword>Alzheimer disease</keyword>
</DOC>